Blay J - Search Results

1

Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.

Baguma-Nibasheka M, Barclay C, Li AW, Geldenhuys L, Porter GA, Blay J, Casson AG, Murphy PR. Baguma-Nibasheka M, et al. Among authors: blay j. Mol Carcinog. 2007 Dec;46(12):971-80. doi: 10.1002/mc.20339. Mol Carcinog. 2007. PMID: 17477358

2

Adenosine suppresses alpha(4)beta(7) integrin-mediated adhesion of T lymphocytes to colon adenocarcinoma cells.

MacKenzie WM, Hoskin DW, Blay J. MacKenzie WM, et al. Among authors: blay j. Exp Cell Res. 2002 May 15;276(1):90-100. doi: 10.1006/excr.2002.5514. Exp Cell Res. 2002. PMID: 11978011

3

Adenosine inhibits the adhesion of anti-CD3-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor.

MacKenzie WM, Hoskin DW, Blay J. MacKenzie WM, et al. Among authors: blay j. Cancer Res. 1994 Jul 1;54(13):3521-6. Cancer Res. 1994. PMID: 8012976

4

Colon adenocarcinoma cells inhibit anti-CD3-activated killer cell induction.

Hoskin DW, Reynolds T, Blay J. Hoskin DW, et al. Among authors: blay j. Cancer Immunol Immunother. 1994 Mar;38(3):201-7. doi: 10.1007/BF01525642. Cancer Immunol Immunother. 1994. PMID: 8124689 Free PMC article.

5

The adhesion of anti-CD3-activated mouse T cells to syngeneic colon adenocarcinoma cells is differentially regulated by protein tyrosine kinase-, protein kinase C-, and cAMP-dependent pathways in the effector cell.

MacKenzie WM, Hoskin DW, Blay J. MacKenzie WM, et al. Among authors: blay j. Biochem Biophys Res Commun. 1999 Feb 16;255(2):460-5. doi: 10.1006/bbrc.1999.0232. Biochem Biophys Res Commun. 1999. PMID: 10049731

6

Adenosine acts through an A3 receptor to prevent the induction of murine anti-CD3-activated killer T cells.

Hoskin DW, Butler JJ, Drapeau D, Haeryfar SM, Blay J. Hoskin DW, et al. Among authors: blay j. Int J Cancer. 2002 May 20;99(3):386-95. doi: 10.1002/ijc.10325. Int J Cancer. 2002. PMID: 11992407 Free article.

7

Chemosensitization of T-47D breast carcinoma cells to TRAIL and Fas receptor-induced killing.

Morgan M, Williams BA, Blay J, Hoskin DW. Morgan M, et al. Among authors: blay j. Anticancer Res. 2002 Mar-Apr;22(2A):673-6. Anticancer Res. 2002. PMID: 12014636

8

Exposure to paclitaxel or vinblastine down-regulates CD11a and CD54 expression by P815 mastocytoma cells and renders the tumor cells resistant to killing by nonspecific cytotoxic T lymphocytes induced with anti-CD3 antibody.

Zhao C, Morgan M, Haeryfar SM, Blay J, Hoskin DW. Zhao C, et al. Among authors: blay j. Cancer Immunol Immunother. 2003 Mar;52(3):185-93. doi: 10.1007/s00262-002-0357-4. Epub 2003 Feb 7. Cancer Immunol Immunother. 2003. PMID: 12649748 Free PMC article.

9

Adenosine stimulation of the proliferation of colorectal carcinoma cell lines. Roles of cell density and adenosine metabolism.

Mujoomdar M, Hoskin D, Blay J. Mujoomdar M, et al. Among authors: blay j. Biochem Pharmacol. 2003 Nov 1;66(9):1737-47. doi: 10.1016/s0006-2952(03)00548-3. Biochem Pharmacol. 2003. PMID: 14563484

10

Adenosine stimulation of proliferation of breast carcinoma cell lines: evaluation of the [3H]thymidine assay system and modulatory effects of the cellular microenvironment in vitro.

Mujoomdar M, Bennett A, Hoskin D, Blay J. Mujoomdar M, et al. Among authors: blay j. J Cell Physiol. 2004 Dec;201(3):429-38. doi: 10.1002/jcp.20089. J Cell Physiol. 2004. PMID: 15389546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,070 results

Search Page